Company profile
Resalis Therapeutics
Tackling metabolic disorders with non-coding RNAs
- Industry
- Biotechnology Research
- Employees
- 12
- Headquarters
- Turin, Piedmont
- Founded
- 2021
- LinkedIn followers
- 3,649
- Office locations
- 1
Resalis Therapeutics company summary
Resalis Therapeutics is a company in the Biotechnology Research industry, headquartered in Turin, Piedmont, founded in 2021. On LinkedIn the company has around 12 employees and 3,649 followers.
What technology does Resalis Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Resalis Therapeutics
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders.
Where is Resalis Therapeutics located?
Resalis Therapeutics lists 1 location.
Compare companies similar to Resalis Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Resalis Therapeutics resalistherapeutics.com | Biotechnology Research | 12 | 2021 | Turin, Piedmont |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Resalis Therapeutics
What does Resalis Therapeutics do?
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders.
How many employees does Resalis Therapeutics have?
Resalis Therapeutics has around 12 employees on LinkedIn.
Where is Resalis Therapeutics headquartered?
Resalis Therapeutics is headquartered in Turin, Piedmont.
When was Resalis Therapeutics founded?
Resalis Therapeutics was founded in 2021.
Build a lead list from companies like Resalis Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.